search
GLP-1 weight loss drugs
Trends
- 1Doctors warn of heat risks for GLP-1 drug users●Amid heat wave, doctors warn of health risks for people taking GLP-1 drugs
As a heat wave grips much of the United States, doctors are warning that people taking GLP-1 medications, such as Ozempic and Wegovy, may face heightened health risks. These drugs can contribute to dehydration, which raises the danger of heat exhaustion and other heat-related illness. Health professionals are advising patients on GLP-1 therapies to drink plenty of fluids, limit strenuous outdoor activity, and watch for warning signs like dizziness and nausea during extreme temperatures.
- 2Hims & Hers Unveils AI-Driven Weight Loss Platform▼Hims & Hers Health (HIMS) Unveils AI Native Weight Loss Care Platform
Telehealth company Hims & Hers Health has announced an AI-native weight loss care platform, building artificial intelligence into how patients receive weight loss treatment and support. The launch positions the company to compete more aggressively in the fast-growing market for weight loss care, where demand for GLP-1 drugs and digital health services has surged. Investors and industry watchers are watching how the move affects the company's growth prospects.
- 3Weight loss drugs may help treat reproductive health issues▼Weight loss drugs could help treat women’s reproductive health issues, experts say
Health experts say weight loss drugs such as GLP-1 medications could offer benefits beyond slimming, potentially helping treat women's reproductive health issues. The suggestion points to a possible new use for a class of medicines already in high demand, and it is drawing attention to how obesity-related treatments might intersect with conditions like polycystic ovary syndrome and fertility problems.